Goldenberg Risk Score (ICD Outcome) Calculator
Risk factor assessment
Enter the patient's clinical findings. The score counts five published predictors; it does not calculate an individual annual ICD-event probability.
In the MADIT-II analysis, patients with zero score factors did not show a detectable all-cause mortality benefit from ICD therapy during the study follow-up. This score alone does not determine ICD eligibility.
This is a research-derived risk stratification score, not a standalone ICD eligibility tool. Apply the evidence to the appropriate population and interpret it alongside current guidelines, competing non-arrhythmic mortality, comorbidities, patient preferences, and clinical judgment.
About the score
The Goldenberg clinical risk score was developed from the MADIT-II population to stratify patients with prior myocardial infarction and left ventricular dysfunction by risk of all-cause mortality, and to examine whether the survival benefit associated with primary-prevention ICD therapy differed across risk groups.
Each of the five selected clinical factors contributes one point. The published study excluded a prespecified very-high-risk (VHR) subgroup from the main score analysis, defined by BUN ≥50 mg/dL and/or serum creatinine ≥2.5 mg/dL; that subgroup was evaluated separately.
Score components
| Factor | Criterion | Points |
|---|---|---|
| Age | >70 years | +1 |
| NYHA class | Class III–IV (>II) | +1 |
| QRS duration | >120 ms | +1 |
| Atrial fibrillation | Present at baseline | +1 |
| BUN | >26 and <50 mg/dL in the main score cohort | +1 |
What the study found
- Zero risk factors: no detectable all-cause mortality benefit from ICD therapy was observed in this analysis.
- One or two factors: the observed survival benefit was strongest in these groups.
- Three or more factors: the estimated benefit was attenuated and not statistically significant in the reported analysis.
- VHR subgroup: BUN ≥50 mg/dL and/or serum creatinine ≥2.5 mg/dL; these patients were analyzed separately and should not be interpreted using the main cohort's score results.
Important: The categories above describe observed treatment-effect findings in the original study. They are not calibrated annual probabilities of appropriate ICD therapy, and they should not be translated into a percentage risk from the total score.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.